Table 1.
Clinical characteristics and laboratory determinations of the study population
| Less than 1 kiwi/week | More or equal than 1 kiwi/week | ||||
|---|---|---|---|---|---|
| N = 1114 (75.2 %) | N = 355 (24.2 %) | ||||
| Mean or Number (N) | SD or % | Mean or Number (N) | SD or % | p value | |
| Age (years) | 54.7 | 14.0 | 55.7 | 12.6 | 0.203 |
| Gender, male (n, %) | 497 | 44.6 | 80 | 22.5 | <0.01 |
| Total cholesterol (mg/dL) | 213.1 | 39.8 | 214.9 | 35.1 | 0.414 |
| HDL-Cholesterol (mg/dL) | 57.8 | 15.6 | 62.3 | 14.3 | <0.01 |
| LDL-Cholesterol (mg/dL) | 133.0 | 36.4 | 132.7 | 31.9 | 0.894 |
| Triglycerides (mg/dL) | 125.7 | 118.9 | 105.7 | 75.5 | <0.01 |
| Fibrinogen (mg/dL) | 376.3 | 89.9 | 363.0 | 82.0 | 0.019 |
| HOMAir | 1.97 | 1.69 | 1.67 | 1.19 | <0.01 |
| Diabetes (n, %) | 88 | 7.9 | 28 | 7.9 | 0.992 |
| Lipid-lowering drugs (n, %) | 213 | 19.1 | 68 | 19.2 | 0.988 |